Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease

Internal Medicine

Volumn 50, Issue 7, 2011, Pages 713-717

  Itatsu, Tomoko ^a   Nagahara, Akihito ^b   Hojo, Mariko ^b   Miyazaki, Akihisa ^c   Murai, Toshio ^b   Nakajima, Mikako ^b   Watanabe, Sumio ^b  

^a Juntendo University Hospital   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

Author keywords

Dysmotility; Endoscopy; Gastrointestinal disease; Reflux symptoms; Serotonin reuptake inhibitors; Ulcer

Indexed keywords

FLUVOXAMINE MALEATE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; ATROPHIC GASTRITIS; BACKACHE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; EPIGASTRIC PAIN; EROSIVE GASTRITIS; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HEARTBURN; HEMATEMESIS; HIATUS HERNIA; HUMAN; LARYNGOPHARYNGEAL REFLUX; MALE; MELENA; NAUSEA; PEPTIC ULCER; REFLUX ESOPHAGITIS; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; SIDE EFFECT; STOMACH CANCER; STOMACH MUCOSA INJURY; STOMACH POLYP; STOMACH ULCER; THORAX PAIN; UPPER GASTROINTESTINAL TRACT; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEPRESSION; DUODENOGASTRIC REFLUX; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; JAPAN; MALE; MIDDLE AGED; PEPTIC ULCER; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 79953741275     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4644     Document Type: Article

References (27)

1. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 52: 53-60, 1995.
2. Stein DJ, Ipser JC, Balkom AJ. Pharmacotherapy for social phobia. Cochrane Database Syst Rev 18: CD001206, 2004.
3. Mulrow CD, Williams JW Jr, Chiquette E, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med 108: 54-64, 2000.
4. Schulberg HC, Magruder KM, deGruy F. Major depression in primary medical care practice. Research trends and future priorities. Gen Hosp Psychiatry 18: 395-406, 1996.
5. Cheeta S, Schifano F, Oyefeso A, Webb L, Ghodse AH. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. The British Journal of Psychiatry 184: 41-47, 2004.
6. Mourilhe P, Stokes PE. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Drug Saf 18: 57-82, 1998.
7. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf 20: 277-287, 1999.
8. PDR staff. Physicians Desk Reference. 58th ed. Medical Economics Company, Inc, Montvale, NJ.
9. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. Br Med J 319: 1106-1109, 1999.
10. Movig KL, Janssen MW, de Waal Malefijt J, Kabel PJ, Leufkens HG, Egberts AC. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 163: 2354-2358, 2003.
11. Tata LJ, Fortun PJ, Hubbard RB, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 22: 175-181, 2005.
12. Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R. Risk of serious upper gastrointestinal events with ncurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 63: 403-408, 2007.
13. Wessinger S, Kaplan M, Choi L, et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 23: 937-944, 2006.
14. Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163: 59-64, 2003.
15. O'Malley PG, Wong PW, Kroenke K, Roy MJ, Wong RK. The value of screening for psychiatric disorders prior to upper endoscopy. J Psychosom Res 44: 279-287, 1998.
16. Lanza FL, Graham DY, Davis RE, Rack MF. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxeninduced acute gastroduodenal injury: effect of scoring method. Dig Dis Sci 35: 1494-1499, 1990.
17. Lanza FL, Royer GL, Nelson RS, Chen TT, Seckman CE, Rack MF. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol 75: 17-21, 1981.
18. Naito Y, Yoshikawa T, Iinuma S, et al. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study. Dig Dis Sci 43S: 83S-89S, 1998.
19. Ables AZ, Baughman OL 3rd. Antidepressants: update on new agents and indications. Am Fam Physician 67: 547-554, 2003.
20. Duman EN, Kesim M, Kadioglu M, Yaris E, Kalyoncu NI, Erciyes N. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci 94: 161-165, 2004.
21. Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med 12: 384-389, 1997.
22. Takeuchi K, Tanaka A, Takahira Y, et al. Selective serotonin reuptake inhibitors (SSRIs) aggravate antral ulcers induced by indomethacin in rat stomachs (abstract 337) Gastroenterology 128 (suppl 2): 48, 2005.
23. Yamamoto T, Abe K, Hattori K, Ishii T, Kuyama Y. High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors. Dig Endosc 22: 77, 2010.
24. de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal antiinflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 65: 795-803, 2008.
25. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Alimentary Pharmacol Ther 27: 31-40, 2008.
26. Lyon DT. Efficacy and safety of famotidine in the management of benign gastric ulcers. Am J Med 81: 33-41, 1986.
27. Florent C. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. Clin Ther 15: 14-21, 1993.